C

CND Life Sciences

43 employees

CND Life Sciences develops an evidence-based tool to help confirm a diagnosis of synucleinopathy.

Basic info

Industry

hospitals and health care

Sectors

Health Diagnostics
Biotechnology
Life Science

Date founded

2017

Funding rounds raised

Total raised

$2.4M

from 1 investors over 1 rounds

C

CND Life Sciences raised $2.4M on October 26, 2020

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

FAQ